So if somebody were to go on a significant low, you know, calorie restricted diet or they were to have bariatric surgery, its right in line, um, Its right there in the 20 to 35 percent lean mass loss group
Bottom line: The science is promising but not definitive, says Ali
These drugs offer substantial potential health benefits, but the combination of intense demand, new uses, and high prices for these treatments is likely to place tremendous pressure on Medicare spending, Part D plan costs, and premiums for Part D coverage.
GLP-1 receptor agonists work like the naturally produced hormone, GLP-1
Stentebjerg LL, Madsen LR, Stving RK, Juhl CB, Vinter CA, Andersen LLT, et al
Older options in the same class include liraglutide (Saxenda), although this is less commonly prescribed than the newer weekly injections